<DOC>
	<DOCNO>NCT01338623</DOCNO>
	<brief_summary>The purpose study compare bioavailability ( rate extent absorption ) two tansulosine 0,4 mg capsule formulation . An open , randomize , two-period crossover study seven-days washout interval conduce 32 healthy male volunteer . The plasma sample obtain 72 hour drug administration . A sensitive specific LC-MS/MS method develop validated determination tansulosine human plasma . Bioequivalence product determine calculate 90 % confidence interval ratio Cmax , AUC 0-72h AUC 0 -- inf .</brief_summary>
	<brief_title>Bioequivalence Study Tansulosine 0,4 mg Capsule Health Subjects -Fed State</brief_title>
	<detailed_description>The study protocol approve Local Ethics Committee ( UNICAMP - Campinas , Brazil ) . The study perform 32 healthy male volunteer . They within 10 % ideal body weight . Biochemical test physical examination carry . Their medical history also obtain . . Volunteers drink caffeine-containing drink 48-hours study . The volunteer give write informed consent participate study . The study design two-single-dose , randomize , open-label , balance , crossover study , two period separate 7-days washout . In period standard breakfast volunteer give single dose formulation ( reference test ) tansulosine 200 mL water . Blood sample ( 8 ml ) collect 0 ( pre-dose ) 01:00 ; 02:00 ; 03:00 ; 04:00 ; 04 ; 30 ; 05:00 ; 05:20 ; 05:40 ; 06:00 ; 06:20 ; 06:40 ; 07:00 ; 07:30 ; 08:00 ; 08:30 ; 09:00 ; 10:00 ; 12:00 ; 24:00 ; 48:00 ; 72:00h . These sample centrifuge immediately keep frozen -20Â°C time analysis . Standard meal serve 4 8h administration . During hospital confinement , volunteer always medical supervision .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<criteria>They within 10 % ideal body weight . Biochemical test physical examination carry . No concomitant medication allow . Volunteers drink caffeinecontaining drink 48hours study . The volunteer give write informed consent participate study . Chronic disease Smokers</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>tansulosine</keyword>
</DOC>